NPC Archive Item: Alitretinoin for severe, refractory chronic hand eczema

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Ruzicka T, Lynde CW, Jemec GBE et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results […]

NPC Archive Item: Restrictions on the import of unlicensed melatonin products

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. MHRA drug procurement advice: Restrictions on the import of unlicensed melatonin products following marketing authorisation for Circadin®▼2mg tablets. 15th August 2008. A licensed melatonin product, (Circadin®▼ 2mg tablets) became […]

NPC Archive Item: Cases of lung cancer reported in clinical trials of inhaled insulin (Exubera®▼)

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. http://www.fda.gov/medwatch/safety/2008/safety08.htm#exubera The FDA in America has issued a Dear Healthcare Professional letter regarding cases of lung cancer in clinical trials and during post-marketing surveillance in patients treated with Pfizer’s […]

NPC Archive Item: Vildagliptin launched in UK

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Vildagliptin▼(Galvus ®), a dipeptidyl peptidase type 4 (DPP-4) inhibitor and vildagliptin/metformin▼ (Eucreas®) have recently been launched in the UK. Vildagliptin is licensed for the treatment of type 2 diabetes […]